• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受Fontan循环治疗的儿童和成人预后变量的比较。

Comparison of prognostic variables in children and adults with Fontan circulation.

作者信息

Ohuchi Hideo, Yasuda Kenji, Miyazaki Aya, Iwasa Toru, Sakaguchi Heima, Shin Ono, Mizuno Masanori, Negishi Jun, Noritake Kanae, Yamada Osamu

机构信息

Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, 5-7-1, Fujishiro-dai, Suita, Osaka 565-8565, Japan.

Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, 5-7-1, Fujishiro-dai, Suita, Osaka 565-8565, Japan.

出版信息

Int J Cardiol. 2014 May 1;173(2):277-83. doi: 10.1016/j.ijcard.2014.03.001. Epub 2014 Mar 5.

DOI:10.1016/j.ijcard.2014.03.001
PMID:24650660
Abstract

BACKGROUND

Non-cardiac complications, such as hepato-renal and metabolic problems, are emerging late after the Fontan operation due to its unique hemodynamics. Consequently, associations between clinical variables and postoperative outcome may change during the prolonged postoperative course.

METHODS AND RESULTS

To determine if child and adult Fontan patients differ in the impact of cardiac and non-cardiac variables on clinical outcome, we prospectively evaluated associations between hemodynamics, neurohumoral factors, exercise variables, hepato-renal function and metabolic variables and unscheduled hospitalization, including death in 167 consecutive child and 116 adult Fontan patients. When compared with child patients, the adult patients showed higher rates of medications, lower cardiac index, higher values of natriuretic peptides, greater renal dysfunction, more cholestatic livers, and more impaired responses to exercise (p<0.05-0.0001). During the follow-up of 3.7 ± 2.1 years, 64 clinical events (37 in adults), including 13 deaths, occurred. A high CVP and low arterial oxygen satutration strongly predicted the child events (p<0.001), whereas these prognostic parameters were marginal in the adults. Instead, renal dysfunction and metabolic abnormality predicted adult events (p<0.05). Neurohumoral activation, low albumin, hyponatremia, and impaired exercise variables equally predicted clinical events in child and adult Fontan patients.

CONCLUSIONS

Distinctive differences in predictive value of clinical variables exist between child and adult Fontan patients. In addition to cardiac issues, we should consider non-cardiac determinents of clinical outcome to maximize our efforts to improve prognosis for adult Fontan survivors.

摘要

背景

由于Fontan手术独特的血流动力学特点,肝肾功能及代谢问题等非心脏并发症在Fontan手术后晚期出现。因此,在术后漫长的病程中,临床变量与术后结局之间的关联可能会发生变化。

方法与结果

为确定儿童和成人Fontan患者在心脏及非心脏变量对临床结局的影响方面是否存在差异,我们前瞻性评估了167例连续的儿童Fontan患者和116例成人Fontan患者的血流动力学、神经体液因子、运动变量、肝肾功能及代谢变量与非计划住院(包括死亡)之间的关联。与儿童患者相比,成人患者的用药率更高、心脏指数更低、利钠肽值更高、肾功能障碍更严重、肝脏胆汁淤积更明显、运动反应受损更严重(p<0.05 - 0.0001)。在3.7±2.1年的随访期间,发生了64例临床事件(成人37例),包括13例死亡。高中心静脉压和低动脉血氧饱和度强烈预测儿童的临床事件(p<0.001),而这些预后参数在成人中作用有限。相反,肾功能障碍和代谢异常预测成人的临床事件(p<0.05)。神经体液激活、低白蛋白、低钠血症及运动变量受损对儿童和成人Fontan患者的临床事件具有同等的预测作用。

结论

儿童和成人Fontan患者在临床变量预测价值方面存在显著差异。除了心脏问题外,我们应考虑临床结局的非心脏决定因素,以最大程度地努力改善成人Fontan手术幸存者的预后。

相似文献

1
Comparison of prognostic variables in children and adults with Fontan circulation.接受Fontan循环治疗的儿童和成人预后变量的比较。
Int J Cardiol. 2014 May 1;173(2):277-83. doi: 10.1016/j.ijcard.2014.03.001. Epub 2014 Mar 5.
2
Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation.Fontan手术晚期患者神经体液因子的临床相关性及预后预测价值
Am Heart J. 2005 Sep;150(3):588-94. doi: 10.1016/j.ahj.2004.10.030.
3
Hyponatremia and its association with the neurohormonal activity and adverse clinical events in children and young adult patients after the Fontan operation.法洛四联症手术后儿童及青年患者的低钠血症及其与神经激素活性和不良临床事件的关联。
Congenit Heart Dis. 2011 Jul-Aug;6(4):304-12. doi: 10.1111/j.1747-0803.2011.00503.x. Epub 2011 Mar 21.
4
Prognostic value of exercise variables in 335 patients after the Fontan operation: a 23-year single-center experience of cardiopulmonary exercise testing.335例Fontan手术后患者运动变量的预后价值:一项为期23年的单中心心肺运动试验经验
Congenit Heart Dis. 2015 Mar-Apr;10(2):105-16. doi: 10.1111/chd.12222. Epub 2014 Sep 8.
5
Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery.运动试验可识别出接受Fontan手术的患者发生发病和死亡的风险增加。
Congenit Heart Dis. 2011 Jul-Aug;6(4):294-303. doi: 10.1111/j.1747-0803.2011.00500.x. Epub 2011 Mar 21.
6
Prognostic value of submaximal exercise data for cardiac morbidity in Fontan patients.亚极量运动数据对 Fontan 患者心源性发病率的预测价值。
Med Sci Sports Exerc. 2014 Jan;46(1):10-5. doi: 10.1249/MSS.0b013e31829f8326.
7
Catheter-measured Hemodynamics of Adult Fontan Circulation: Associations with Adverse Event and End-organ Dysfunctions.经导管测量的成人Fontan循环血流动力学:与不良事件和终末器官功能障碍的关联
Congenit Heart Dis. 2016 Dec;11(6):589-597. doi: 10.1111/chd.12345. Epub 2016 Mar 2.
8
Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.法洛四联症根治术后出现蛋白丢失性肠病前、后血液动力学特征。
Eur J Cardiothorac Surg. 2013 Mar;43(3):e49-57. doi: 10.1093/ejcts/ezs714.
9
Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.波生坦可改善 Fontan 术后青少年和成人的运动能力:TEMPO(Fontan 患者内皮素受体拮抗剂治疗,一项随机、安慰剂对照、双盲研究,测量峰值耗氧量)研究。
Circulation. 2014 Dec 2;130(23):2021-30. doi: 10.1161/CIRCULATIONAHA.113.008441. Epub 2014 Oct 20.
10
MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.MELD-XI 评分与 Fontan 手术后患者的心脏死亡率或移植。
Heart. 2013 Apr;99(7):491-6. doi: 10.1136/heartjnl-2012-303347. Epub 2013 Feb 13.

引用本文的文献

1
Albuminuria Prevalence in Fontan Patients: A Systematic Review and Meta-Analysis.Fontan 患者的白蛋白尿患病率:一项系统评价和荟萃分析。
Pediatr Cardiol. 2024 Dec 17. doi: 10.1007/s00246-024-03736-x.
2
Peak Oxygen Consumption Scaled to Body Composition Is Associated With Mortality and Morbidity in People With a Fontan Circulation.根据身体成分调整的最大耗氧量与接受Fontan循环治疗的患者的死亡率和发病率相关。
J Am Heart Assoc. 2024 Dec 17;13(24):e034944. doi: 10.1161/JAHA.123.034944. Epub 2024 Dec 14.
3
Insulin Resistance after Fontan Palliation.
Fontan姑息术后的胰岛素抵抗
Pediatr Cardiol. 2024 Oct 7. doi: 10.1007/s00246-024-03663-x.
4
Care Pattern for Fontan-Associated Liver Disease by Academic Pediatric Hepatologists in Canada.加拿大儿科学术肝脏病专家对Fontan相关肝病的护理模式
JPGN Rep. 2022 Jun 21;3(3):e207. doi: 10.1097/PG9.0000000000000207. eCollection 2022 Aug.
5
Prevalence of Abnormal Hemoglobin A1c Values in Single Ventricle Patients Following Fontan Palliation.Fontan 姑息术后单心室患者异常血红蛋白 A1c 值的发生率。
Pediatr Cardiol. 2023 Jun;44(5):1083-1091. doi: 10.1007/s00246-023-03141-w. Epub 2023 Mar 24.
6
Fitter Fontans for future-Impact of physical exercise on cardiopulmonary function in Fontan patients.为未来打造更健康的Fontan循环——体育锻炼对Fontan患者心肺功能的影响
Front Cardiovasc Med. 2022 Sep 12;9:972652. doi: 10.3389/fcvm.2022.972652. eCollection 2022.
7
Fontan Circulation Associated Organ Abnormalities Beyond the Heart, Lungs, Liver, and Gut: A Systematic Review.法洛四联症循环相关的心脏、肺、肝脏和肠道以外器官异常:一项系统评价
Front Cardiovasc Med. 2022 Mar 22;9:826096. doi: 10.3389/fcvm.2022.826096. eCollection 2022.
8
A Multimodal Score Accurately Classifies Fontan Failure and Late Mortality in Adult Fontan Patients.一种多模态评分可准确分类成人Fontan患者的Fontan衰竭和晚期死亡率。
Front Cardiovasc Med. 2022 Mar 10;9:767503. doi: 10.3389/fcvm.2022.767503. eCollection 2022.
9
Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.血液生物标志物与心功能及不良结局的相关性研究:一项年轻 Fontan 队列研究
J Am Heart Assoc. 2021 Feb;10(5):e015022. doi: 10.1161/JAHA.119.015022. Epub 2021 Feb 24.
10
Author Response to "Letter to the Editor" "Inferior Vena Cava Diameter and Fontan-Related Nephropathy: Considerations About Clinical Usefulness and Physiology" (PEDC-D-20-00743).作者对《致编辑的信:下腔静脉直径与Fontan相关肾病——关于临床实用性和生理学的思考》(PEDC-D-20-00743)的回复
Pediatr Cardiol. 2021 Jan;42(1):219-220. doi: 10.1007/s00246-020-02517-6. Epub 2021 Jan 19.